The company is developing a platform of drugs that increase the amount of oxygen in the blood and tissues to treat life threatening conditions. The initial focus are cancer patients treated with radiotherapy. Phase Ib/II clinical trials are in progress for the platform's first drug and have shown therapeutic reversal of tumor hypoxia and evidence of improved survival. They have received orphan drug designation from the US FDA for glioblastoma multiforme and also for sickle cell disease. The company has approved IND’s for stroke and sickle cell disease. The stroke trial is in progress.
Asking Price Available On Request
Sales Available On Request
Profit Available On Request
You May Also Like
Toxicology Lab in Southwest – Very Profitable #454274 posted Sep 21, 2016
- Las Vegas, Nevada, United States
This is an opportunity to acquire an established and extremely profitable drug and urine testing laboratory. This business is completely turn-key and fully licensed including a Medicare License, Medicaid License, CLIA Certification and COLA Accreditation. The laboratory offers services to consumers,...
Pre-Clinical CRO with Patents #466338 posted Apr 11, 2017
- San Diego, California, United States
With its patented technology, this company is helping to solve a $302 billion per year ophthalmic problem in the United States. It holds the exclusive license to patented technology for manufacturing implants and the use of the implants for producing experimental retina diseases in the large mammalian...
Clinical Laboratory PPO Insurance Contracts #464407 posted Mar 11, 2017
- Los Angeles County, California, United States
Good Contracts! Operating since 1950-is…in the fancy part of West LA County – you can move it if rent (expires 2017) is to expensive or not needed. Lease $11,000/month, shared 5,000 SF space. Six employees, all what is needed, is in place. The right buyer is the one who can profit from laboratory’s...
Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.